Neurocognitive and Radiological Assessments in Adult Moyamoya Undergoing Surgery

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

80 participants

Study Classification

INTERVENTIONAL

Study Start Date

2016-03-31

Study Completion Date

2018-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Adult patients with moyamoya disease (MMD) are reported to suffer from considerable impairment of executive function/attention. Although reduced cerebrovascular reserve (CVR) in frontal areas has been detected by perfusion MRI and then confirmed to be associated with executive dysfunction in adult MMD, the structural and functional changes is still unclear with progression of executive dysfunction. Furthermore, it is very important to study the association between the neurocognitive and radiological improvement after surgical revascularization, so as to help detecting cerebral regions which are involved in executive deterioration or improvement after surgery. Then the investigators can determine whether these regions can be used as indicators to decide rational therapeutic schedule and timing of adult MMD with executive dysfunction.

Thus the aim of this study is to primarily find out the neuropsychological and radiological correlates in adult MMD, and then to quantitatively evaluate the effectiveness of surgical revascularization in prevention of executive dysfunction in adult MMD.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

The Adult Hemorrhagic Moyamoya Surgery Study

NCT02319980

Moyamoya Stroke

UNKNOWN PHASE3

Effect of Surgical Revascularization on Hemorrhagic Moyamoya Disease

NCT03627975

Moyamoya Disease

UNKNOWN NA

Cerebral Small Vessel Disease and Perioperative Covert Stroke

NCT04443933

Cerebral Small Vessel Diseases Covert Postoperative Stroke

UNKNOWN

The Role of Cerebral Hemodynamics in Moyamoya Disease

NCT00629915

Moyamoya Stroke

COMPLETED

Direct Bypass Versus Indirect Bypass in Treatment of Adults Hemorrhagic Moyamoya Disease

NCT02982135

Moyamoya Disease

UNKNOWN NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Previous studies of adult moyamoya disease (MMD) have revealed that vascular cognitive impairment (VCI) is the consequence of ischemic damage to dynamic factors such as cerebral hypoperfusion, rather than to cerebral gray matter. However, it is still unclear which regions are affected by MMD and how these regions respond to the progressive cognitive decline. In other way, the investigators need to detect spatial patterns in the brain activity of MMD in order to understand its pathophysiological nature.

Surgical revascularization has been accepted as the only effective form of treatment in preventing future ischemic episodes. However, its effectiveness in cognitive protection is still unknown. Thus, the investigators determine to quantitatively evaluate cognitive and radiological outcomes in adult MMD postoperatively and during follow-ups.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Moyamoya Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

surgical revascularization

Patients will be assigned to either surgical or conservative treatment depending on their clinical symptoms and radiological assessment.

Group Type EXPERIMENTAL

Surgical Revascularization

Intervention Type PROCEDURE

Most patients in this group will be performed combined procedures of superficial temporal to middle cerebral artery bypass (STA-MCA) and encephalo-duro-myo-synangiosis (EDMS). Patients not suitable for combined procedures will be performed EDMS.

conservative treatment

Normal conservative treatment without surgical intervention.

Group Type EXPERIMENTAL

Conservative treatment

Intervention Type OTHER

Patients will be medically treated with antiplatelets, antiepileptics, antihypertensives and vasodilators depending on the presentation.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Surgical Revascularization

Most patients in this group will be performed combined procedures of superficial temporal to middle cerebral artery bypass (STA-MCA) and encephalo-duro-myo-synangiosis (EDMS). Patients not suitable for combined procedures will be performed EDMS.

Intervention Type PROCEDURE

Conservative treatment

Patients will be medically treated with antiplatelets, antiepileptics, antihypertensives and vasodilators depending on the presentation.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Right-handed Chinese people aged over 18 years
* No evidence of recent or remote infarct in the cerebral cortical, basal ganglia, brainstem or cerebellum
* No evidence of recent or remote intracerebral hemorrhage
* Diagnosis confirmed by digital subtraction angiography (DSA) according to Suzuki scale
* No surgical intervention before recruitment
* Physically capable of cognitive testing
* Geographically accessible and reliable for follow-up.

Exclusion Criteria

* Significant neurological diseases or psychiatric disorders that could affect cognition
* Other cerebrovascular diseases (such as atherosclerosis or vasculitides) likely to cause focal cerebral ischemia
* Concomitant cerebrovascular diseases (such as aneurysms or arteriovenous malformation) that need surgical intervention
* Severe systemic diseases
* Pregnant or perinatal stage women
* Any diseases likely to death within 2 yeas
* Taking drugs such as benzodiazepine clonazepam
* Any contraindications or allergy to aspirin
* Allergy to iodine or radiographic contrast media
* Past history of surgical revascularization
* Concurrent participation in any other experimental treatment trial
* Any condition that in the surgeon's judgment suggests the patient an unsuitable surgical candidate.

Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes